Fact-checked by Grok 2 weeks ago

Staphylococcus

Staphylococcus is a genus of Gram-positive, catalase-positive, facultative anaerobic bacteria characterized by spherical cocci that typically occur in grape-like clusters, measuring 0.5–1.5 μm in diameter, and are non-motile and non-spore-forming.^[1] These bacteria are widely distributed in the environment, particularly as commensals on the skin, mucous membranes, and respiratory tracts of humans and other mammals, with over 80 recognized species as of 2025.^[2]^[1] Traditionally classified into coagulase-positive and coagulase-negative groups based on their ability to coagulate plasma, the genus includes prominent species such as Staphylococcus aureus (coagulase-positive, a major human pathogen causing skin infections, bacteremia, and toxic shock syndrome) and coagulase-negative species like Staphylococcus epidermidis (common skin commensal associated with device-related infections) and Staphylococcus saprophyticus (a frequent cause of urinary tract infections in young women).^[1]^[3] While many staphylococci are harmless colonizers, they exhibit remarkable adaptability, including salt tolerance, biofilm formation, and antibiotic resistance, contributing to their role as opportunistic pathogens in healthcare settings and beyond.^[4] The genus belongs to the family Staphylococcaceae, with a low DNA G+C content of 30–40 mol%, distinguishing it from related genera like Micrococcus.^[3]

Taxonomy

Classification History

The genus Staphylococcus was first described in 1880 by Scottish surgeon Alexander Ogston, who observed grape-like clusters of cocci in pus from a surgical abscess in a knee joint, noting their role in wound infections.^[5] In 1884, Friedrich Julius Rosenbach formally established the genus Staphylococcus, naming the type species S. aureus based on its golden pigmentation, and describing it as consisting of spherical bacteria arranged in irregular clusters resembling bunches of grapes.^[6] The etymology derives from the Greek words staphyle (bunch of grapes), referring to the characteristic cluster formation, and kokkos (berry or grain), denoting the spherical shape of the cells.^[7] Early classifications of Staphylococcus relied on morphological and basic biochemical characteristics, such as Gram staining, catalase positivity, and arrangement in clusters, initially grouping them within the family Micrococcaceae as established in Bergey's Manual in 1923 and 1957.^[8] A significant advancement occurred in the 1930s with the development of the coagulase test, which distinguished coagulase-positive species like S. aureus—capable of clotting plasma—from coagulase-negative species, enabling better differentiation based on pathogenicity and facilitating clinical identification.^[9] Modern taxonomic revisions of the Staphylococcus genus have been driven by molecular techniques, particularly 16S rRNA gene sequencing, which has revealed high genetic similarity (90-99%) among species and supported phylogenetic analyses since the 1990s.^[10] Whole-genome sequencing has further refined classifications, leading to the recognition of over 70 distinct species as of 2025, with S. aureus retained as the type species, and ongoing reclassifications based on average nucleotide identity and digital DNA-DNA hybridization.^[8]

Major Species and Groups

The genus Staphylococcus is primarily divided into two major groups based on the production of coagulase, an enzyme that causes plasma to clot: coagulase-positive staphylococci (CoPS) and coagulase-negative staphylococci (CoNS).^[1] CoPS include species such as Staphylococcus aureus and Staphylococcus pseudintermedius, which are often associated with more aggressive infections due to this virulence factor.^[11] In contrast, CoNS encompass a larger diversity of species, including Staphylococcus epidermidis, Staphylococcus saprophyticus, and Staphylococcus lugdunensis, which are typically opportunistic pathogens.^[4] Among human-associated species, S. aureus stands out as a primary pathogen capable of causing a wide range of infections, from skin abscesses to severe systemic diseases.^[12] S. epidermidis is a common commensal on human skin but acts as an opportunistic pathogen in nosocomial settings, particularly in device-related infections.^[4] S. saprophyticus is notable for causing urinary tract infections in young women and is distinguished by its resistance to novobiocin, aiding in its identification.^[13] S. lugdunensis, while classified as CoNS, exhibits enhanced virulence similar to CoPS in endocarditis and skin infections.^[14] Animal-associated species include S. pseudintermedius, which primarily colonizes and infects dogs and cats, often causing pyoderma and wound infections.^[15] Staphylococcus hyicus is a key pathogen in pigs, responsible for exudative epidermitis, a contagious skin disease in piglets.^[16] Phylogenetically, Staphylococcus species are analyzed using multi-locus sequence typing (MLST), which targets housekeeping genes to reveal evolutionary relationships and clonal complexes.^[17] This approach highlights close relatedness among species, with core genomes sharing approximately 1.8–2.8 Mb of conserved sequences across the genus, reflecting a common ancestral backbone despite accessory gene variations that drive host adaptation.^[18]

Physical Characteristics

Morphology and Cell Structure

Staphylococci are Gram-positive bacteria characterized by their coccal shape, appearing as spherical cells typically measuring 0.5–1.5 μm in diameter.^[19] These cells divide in multiple planes, resulting in characteristic irregular clusters that resemble bunches of grapes under light microscopy.^[1] The cell wall of Staphylococcus species is a prominent feature, consisting of a thick peptidoglycan layer that ranges from 20–40 nm in thickness and provides structural rigidity.^[20] Embedded within this peptidoglycan matrix are teichoic acids, including wall teichoic acids (WTAs) covalently linked to the glycan strands via phosphodiester bonds and lipoteichoic acids (LTAs) anchored to the cytoplasmic membrane.^[21] These teichoic acids, often ribitol-based in staphylococci, contribute to the overall polyanionic nature of the cell wall while facilitating interactions that influence surface charge.^[21] Most Staphylococcus species lack endospores, flagella, and prominent capsules, distinguishing them from other Gram-positive bacteria; however, thin microcapsules may be present in certain strains of S. aureus, visible only under electron microscopy with specific labeling.^[1] The cells are facultative anaerobes, and in S. aureus, a golden-yellow pigment known as staphyloxanthin, produced via a carotenoid biosynthesis pathway, imparts the characteristic coloration to colonies.^[22] Additionally, the surface of S. aureus features variable proteins, such as protein A, which is covalently anchored to the peptidoglycan via sortase enzymes, contributing to the heterogeneous outer layer observed in high-resolution imaging.^[21]

Growth and Metabolic Properties

Staphylococci exhibit optimal growth at 37°C, which corresponds to human body temperature, and within a pH range of 7.0 to 7.5. They thrive in nutrient-rich media such as nutrient agar or blood agar, which support robust colony formation under aerobic conditions.^[1] These bacteria demonstrate remarkable tolerance to high salt concentrations, growing in up to 10% NaCl, facilitated by the accumulation of osmoprotectants like proline that maintain cellular osmotic balance.^[23] This salt tolerance contributes to their ability to colonize salty skin environments.^[24] In terms of metabolic profiles, most Staphylococcus species ferment glucose anaerobically, producing acid but no gas.^[25] Staphylococcus aureus specifically produces acid from mannitol fermentation, a trait that distinguishes it from many coagulase-negative species, whereas lactose fermentation is generally absent or weak across the genus.^[26] Staphylococci are catalase-positive, enabling the breakdown of hydrogen peroxide into water and oxygen, which differentiates them from catalase-negative streptococci.^[27] They are oxidase-negative and primarily utilize aerobic respiration involving cytochromes for energy production, though they can switch to fermentation under anaerobic conditions.^[28] Staphylococci do not form spores, relying instead on adaptive stress responses for survival in stationary phase. Biofilm formation on abiotic and biotic surfaces is a key survival strategy, allowing communities of cells to adhere via polysaccharide intercellular adhesin and resist environmental stresses such as desiccation and antimicrobials.^[29] The alternative sigma factor B (σ^B) plays a critical role in regulating gene expression during stationary phase, enhancing tolerance to heat, oxidative stress, and osmotic challenges.^[30]

Identification Methods

Biochemical Tests

Biochemical tests play a crucial role in the presumptive identification of Staphylococcus species in clinical settings, leveraging enzymatic reactions and metabolic properties to distinguish them from other gram-positive cocci and differentiate within the genus. These assays are simple, cost-effective, and widely used in microbiology laboratories for initial screening before more specific tests. Following Gram staining, which typically reveals gram-positive cocci in grape-like clusters, biochemical evaluations confirm staphylococcal characteristics.^[31] The catalase test serves as a primary differentiator for the genus Staphylococcus. This assay detects the catalase enzyme, which decomposes hydrogen peroxide (H₂O₂) into water and oxygen gas, producing visible bubbles upon addition of 3% H₂O₂ to a bacterial smear on a glass slide. All Staphylococcus species yield a positive result with effervescence, distinguishing them from catalase-negative genera like Streptococcus.^[32] The DNase (deoxyribonuclease) test evaluates extracellular DNase production, which hydrolyzes DNA in the medium. Isolates are streaked on DNase agar and incubated at 37°C for 24 hours, followed by flooding with 1 N HCl; a clear zone around colonies indicates positivity. This reaction is positive for S. aureus (75% sensitivity, 96% specificity) and select coagulase-negative staphylococci (CoNS), aiding in S. aureus presumptive identification, though some CoNS may yield false positives.^[33] Mannitol salt agar (MSA) combines selectivity and differentiation through high salt (7.5% NaCl) tolerance and mannitol fermentation. Staphylococcus species grow on MSA due to halotolerance, but S. aureus ferments mannitol, lowering pH and turning the phenol red indicator yellow, often with yellow halos around colonies after 24-hour incubation at 37°C. This test offers 94% sensitivity for S. aureus but 79% specificity, as certain CoNS like S. caprae can also ferment mannitol.^[33] Novobiocin susceptibility testing differentiates CoNS species, particularly in urinary isolates. A 5 μg novobiocin disk is placed on an inoculated Mueller-Hinton agar plate, incubated at 35°C for 18–24 hours; resistance (inhibition zone ≤12 mm or none) identifies S. saprophyticus, while susceptibility (>16 mm zone) indicates other CoNS like S. epidermidis. This phenotypic marker, linked to genetic resistance traits, achieves high accuracy (89.1% concordance with molecular methods) for S. saprophyticus in clinical samples.^[34] Hemolysis patterns on 5% sheep blood agar provide additional clues after 24-hour aerobic incubation at 37°C. S. aureus typically exhibits beta-hemolysis, with clear zones of complete red blood cell lysis around colonies due to alpha-toxin and other hemolysins, whereas most CoNS show alpha-hemolysis (partial greenish discoloration) or gamma-hemolysis (no change). Staphylococcus species demonstrate facultative anaerobic growth, proliferating under both aerobic and anaerobic conditions, though at a reduced rate anaerobically due to shifts in metabolic pathways like enhanced nitrogen utilization. This adaptability, observed in broth or agar media incubated without oxygen, supports their colonization in oxygen-variable host sites and distinguishes them from obligate aerobes.

Coagulase and Other Serological Tests

The coagulase test is a key serological method for differentiating Staphylococcus aureus from other staphylococcal species by detecting the enzyme coagulase, which converts fibrinogen in plasma to fibrin, leading to clotting.^[35] This test is performed using rabbit plasma and exists in two primary formats: the slide test, which identifies bound coagulase (clumping factor) on the bacterial cell surface through visible clumping within seconds, and the tube test, which detects free coagulase in the supernatant after incubation, resulting in plasma clot formation after 4–24 hours.^[36] The slide test is rapid but requires confirmation with the tube test for accuracy, as it may miss strains with low bound coagulase expression.^[37] The coagulase test shows high specificity for S. aureus, with positive results also observed in related species such as S. intermedius and S. pseudintermedius, but negative in most coagulase-negative staphylococci (CoNS).^[38] In clinical microbiology, a positive tube coagulase is considered definitive for S. aureus identification, though rare variants like certain staphylocoagulase genotypes (e.g., genotypes X and XI) may produce weak or no clotting, leading to false negatives.^[39] Protein A, a surface-anchored protein in S. aureus that binds the Fc region of immunoglobulin G, is detected via latex agglutination assays, where latex particles coated with IgG cause visible clumping in positive samples within minutes.^[40] These tests, such as Pastorex Staph-Plus or Staphaurex, often combine detection of Protein A with clumping factor and capsular polysaccharides for enhanced sensitivity and specificity exceeding 95% in identifying S. aureus from CoNS.^[41] The thermonuclease (DNase) test serves as a reliable adjunct to coagulase testing, detecting the thermostable nuclease enzyme produced almost exclusively by S. aureus, which degrades DNA in toluidine blue agar, forming a pink halo after 4 hours of incubation at 37°C.^[42] This test offers greater sensitivity than tube coagulase alone (up to 100% when combined) and is particularly useful for confirming presumptive S. aureus isolates or resolving ambiguous coagulase results, as it withstands heating to 100°C without loss of activity.^[43] For rapid identification of CoNS species, latex agglutination kits target species-specific antigens; for example, certain commercial assays distinguish S. epidermidis (typically negative for clumping factor and Protein A) from S. lugdunensis, which may show weak positive reactions due to its bound coagulase-like activity, necessitating additional tests like ornithine decarboxylase for confirmation.^[44] These kits enable differentiation within 5–10 minutes, improving workflow in resource-limited settings.^[45] Limitations of coagulase and related serological tests include false negatives in approximately 1–5% of S. aureus mutants lacking functional coagulase genes, as well as potential false positives from autoagglutination in some CoNS strains.^[39] Historically, the coagulase test played a pivotal role in 1950s hospital epidemiology by enabling rapid tracking of coagulase-positive S. aureus during penicillin-resistant outbreaks, facilitating infection control measures.^[46] Coagulase production also serves as a marker of virulence, though its mechanistic role in pathogenesis is addressed elsewhere.^[38]

Molecular and Advanced Identification Methods

In addition to traditional methods, modern clinical laboratories increasingly employ matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for rapid identification of Staphylococcus species. This technique analyzes the protein profile of bacterial colonies, providing species-level identification within minutes with accuracy exceeding 95% for common staphylococci, including differentiation of S. aureus from CoNS. It has largely replaced manual biochemical testing in high-throughput settings due to its speed and cost-effectiveness after initial instrument investment.^[47] Molecular methods, such as polymerase chain reaction (PCR) targeting genes like nuc (thermonuclease) for S. aureus or mecA for methicillin resistance, offer high specificity and sensitivity (>98%) for definitive identification, especially in outbreaks or antibiotic susceptibility contexts. Commercial systems like GeneXpert enable real-time PCR directly from clinical samples, reducing turnaround time to under 2 hours as of 2025. These approaches complement serological tests and are particularly valuable for detecting rare or atypical strains.^[48]

Genetics and Molecular Biology

Genome Structure

The genomes of Staphylococcus species consist of a single circular chromosome typically ranging in size from 2.0 to 3.5 megabases (Mb), with a G+C content of 30-35% and approximately 2,500 to 3,000 protein-coding genes.^[49]^[50] For example, the reference strain S. aureus NCTC 8325 has a chromosome of 2.81 Mb containing 2,878 genes, while S. epidermidis ATCC 12228 features a 2.50 Mb genome with 2,307 genes.^[51] This architectural conservation across the genus supports essential cellular functions, though interspecies differences reflect adaptations to diverse ecological niches. The Staphylococcus genome is divided into a core genome and an accessory genome. The core genome, comprising about 75% of the total, includes highly conserved housekeeping genes essential for basic processes such as DNA replication (dnaA, dnaB) and transcription (rpoA, rpoB).^[52] These elements exhibit minimal variation among strains, forming a stable backbone estimated at 1,400-1,500 genes in pangenome analyses of S. aureus.^[53] In contrast, the accessory genome—accounting for the remaining 25%—arises from horizontal gene transfer and introduces strain-specific traits; it often displays a distinct G+C content lower than the core, reflecting acquisition from distantly related bacteria.^[54] A key component of the accessory genome is the staphylococcal cassette chromosome mec (SCCmec), a mobile genetic element integrated at the orfX site near the chromosome origin.^[55] SCCmec spans 20-60 kilobases (kb) and harbors the mecA gene complex for methicillin resistance along with cassette chromosome recombinase (ccr) genes (ccrAB or ccrC) that mediate excision and transfer.^[56] Over a dozen SCCmec types have been identified, with types IV and V prevalent in community-acquired methicillin-resistant S. aureus (MRSA) due to their compact structure.^[57] Plasmids in Staphylococcus are typically small, ranging from 2 to 30 kb, and serve as vehicles for accessory genes encoding antibiotic resistance or toxins.^[58] These extrachromosomal elements replicate independently via rolling-circle or theta mechanisms and can be lost or gained dynamically. For instance, plasmid pUB110, approximately 4.6 kb in size, carries the aadD gene conferring resistance to aminoglycosides such as kanamycin and tobramycin.^[59]^[60] Prophages, integrated as part of the accessory genome at specific attachment sites (e.g., attB loci), contribute significantly to genomic diversity, with S. aureus strains often harboring 2-4 such elements totaling 40-50 kb each.^[61] These temperate siphoviruses encode superantigens like staphylococcal enterotoxin A (SEA), which is lysogenized via phage φSa3 and enhances immune modulation.^[62] Comparative genomics reveals 20-30% variability in gene content between Staphylococcus strains, largely driven by prophage mosaicism and recombination at integration sites.^[51] This plasticity underscores the genus's adaptability without altering the core chromosomal framework.

Key Molecular Mechanisms

Staphylococcus species employ quorum sensing primarily through the accessory gene regulator (agr) system, which enables density-dependent coordination of gene expression via autoinducing peptides (AIPs). The agr locus consists of two divergent operons: P2, encoding the signal peptide precursor AgrD, the processing enzyme AgrB, the histidine kinase AgrC, and the response regulator AgrA; and P3, producing the effector RNAIII. Upon reaching a threshold bacterial density, secreted AIPs bind to AgrC, activating AgrA phosphorylation, which upregulates P2 and P3 transcription, leading to amplified AIP production and RNAIII expression that post-transcriptionally regulates virulence factors such as toxins and adhesins while repressing surface proteins.^[63] This system is conserved across staphylococci and pivotal for transitioning from colonization to invasive behavior.^[64] Two-component systems (TCSs) in Staphylococcus facilitate environmental sensing and adaptive responses through sensor kinases and response regulators. The WalKR (YycFG) TCS, essential for viability, monitors cell wall integrity; WalK detects peptidoglycan stress, phosphorylating WalR to activate genes for cell wall metabolism, including autolysins and penicillin-binding proteins, ensuring proper septum formation and division.^[65] Similarly, the MgrA TCS responds to oxidative and nitrosative stress; MgrA, a global regulator, modulates expression of capsule, biofilm, and resistance genes by binding promoter regions, often in interplay with other TCSs like ArlRS.^[66] Staphylococcus encodes around 16 TCSs, with these exemplars highlighting their role in maintaining cellular homeostasis under host pressures.^[65] Horizontal gene transfer (HGT) in Staphylococcus occurs via conjugative plasmids and phage-mediated transduction, disseminating antibiotic resistance and toxin genes. Conjugative plasmids, such as pGO1, encode transfer machinery including relaxases and coupling proteins, enabling direct cell-to-cell plasmid mobilization, often carrying multidrug resistance cassettes like those for tetracyclines or macrolides.^[67] Phage transduction, particularly generalized and lateral forms by temperate siphoviruses, packages bacterial DNA into virions; staphylococcal phages like φ11 transfer chromosomal segments or entire plasmids, with lateral transduction allowing hypermobility of up to 43 kb fragments at frequencies exceeding 10^{-5} per phage particle.^[68] These mechanisms drive rapid evolution, with in vivo HGT rates surpassing in vitro observations by orders of magnitude.^[69] Sigma factors in Staphylococcus direct RNA polymerase to stress-responsive promoters, with SigB being central for adaptation. SigB, an alternative sigma factor, activates over 100 genes under environmental stresses like heat, salt, or antibiotics, promoting biofilm formation, persistence, and reduced susceptibility by upregulating chaperones, proteases, and extracellular matrix components such as poly-N-acetylglucosamine.^[70] RNAIII, the agr effector, integrates with sigma factor regulation by binding mRNAs to destabilize surface protein transcripts (e.g., protein A) while stabilizing toxins, thus linking quorum sensing to post-transcriptional control and enhancing SigB-mediated persistence in stationary phase.^[71] This interplay underscores SigB's role in chronic infection resilience without overlapping core genome elements.^[72]

Ecology and Habitat

Natural Reservoirs

Staphylococci are primarily known as commensal bacteria on host skin and mucous membranes, but they also occupy various environmental niches outside of living hosts, albeit at low abundances. Species such as Staphylococcus sciuri and its relatives are frequently detected in soil and water bodies contaminated by animal feces or decaying organic matter, where they persist as part of the microbial community in these low-nutrient environments.^[73]^[74] These bacteria contribute to the baseline environmental load of staphylococci, though their density remains minimal compared to host-associated populations. Additionally, staphylococci, including S. aureus, have been isolated from untreated water sources, highlighting their adaptability to aquatic settings influenced by anthropogenic or animal inputs.^[75] In food sources, staphylococcal contamination often arises during production and handling, particularly in dairy and meat products. S. aureus is a common contaminant in raw or unpasteurized milk, where it enters via bovine mastitis in dairy animals, leading to potential food safety risks if not properly processed.^[76]^[77] Meat products from livestock can similarly harbor staphylococci due to slaughterhouse processing or fecal cross-contamination, with species like S. sciuri associated with animal-derived foods.^[78] This environmental persistence in food matrices underscores the importance of hygiene practices to prevent staphylococcal proliferation during storage. On inanimate surfaces, staphylococci demonstrate notable survival capabilities due to their desiccation tolerance, allowing S. aureus to remain viable on dry materials like plastic, glass, or metal for periods extending from days to weeks, and in some cases months.^[79]^[80] This resilience facilitates their role in foodborne outbreaks, as contaminated surfaces in processing environments can transfer bacteria to food items, amplifying dissemination risks. Staphylococci's tolerance to harsh conditions, such as low humidity and nutrient scarcity, further supports their longevity in these non-host settings. Zoonotic reservoirs in wild animals represent another environmental dimension, with species like Staphylococcus delphini identified as commensals on marine mammals such as dolphins, where they colonize skin and mucous membranes.^[81]^[82] Other staphylococci, including S. aureus, have been detected in diverse wildlife, serving as potential bridges to domestic animals or humans through shared environments, though wild animal reservoirs maintain distinct ecological roles separate from primary host skin microbiomes.^[83]

Host Colonization Patterns

Staphylococcus species, particularly Staphylococcus aureus and coagulase-negative staphylococci (CoNS) such as S. epidermidis, commonly establish asymptomatic colonization in humans, with the anterior nares serving as the primary reservoir for S. aureus in approximately 20-30% of healthy adults.^[84] Other key sites include the skin, throat, and perineum, where CoNS like S. epidermidis predominate, often exhibiting higher carriage rates in moist areas such as the perineal region.^[85] These colonization patterns reflect the bacteria's adaptation to host mucosal and cutaneous environments, enabling persistent carriage without eliciting overt immune responses.^[86] Adhesion to host tissues is mediated by surface proteins that bind extracellular matrix components and epithelial ligands. For instance, fibronectin-binding proteins (FnBA and FnBB) facilitate attachment to fibronectin on mucosal surfaces, while clumping factor A (ClfA) promotes initial adherence to fibrinogen and fibrin.^[86] In the nasal cavity, clumping factor B (ClfB) specifically interacts with loricrin and cytokeratin 10 on squamous epithelial cells, enhancing mucosal colonization.^[84] These mechanisms, akin to certain virulence factors, allow staphylococci to anchor firmly to host cells during the early stages of carriage.^[87] Persistence of colonization is supported by biofilm formation on epithelial surfaces, which shields bacteria from host defenses and antimicrobials, and immune evasion strategies such as protein A (SpA), which binds IgG Fc regions to inhibit phagocytosis.^[87] Persistent carriers, comprising 10-30% of the population, maintain higher bacterial loads and are prone to recolonization with the same strain.^[84] For methicillin-resistant S. aureus (MRSA), nasal colonization rates range from 1-3% globally in adults, influenced by strain-specific adaptations that favor long-term carriage.^[88] Interspecies transmission occurs between humans and animals, notably with S. pseudintermedius from companion dogs to owners through close contact, leading to human skin and nasal colonization.^[89] Transmission from colonized mothers to newborns via close contact in the early postnatal period is documented, with acquisition of S. aureus occurring within the first month of life in many cases.^[90] These patterns underscore the role of direct contact in sustaining staphylococcal reservoirs across host populations.^[91]

Pathogenesis

Virulence Factors

Staphylococcus species, particularly S. aureus, utilize an arsenal of virulence factors to colonize host tissues, evade immune clearance, and inflict damage. These molecules encompass secreted toxins, degradative enzymes, adhesins for host attachment, and protective surface structures, enabling the bacterium to establish persistent infections.^[92] Secreted toxins include potent superantigens that dysregulate the immune response. Toxic shock syndrome toxin-1 (TSST-1), a 22 kDa protein, binds major histocompatibility complex class II and T-cell receptor Vβ chains, triggering polyclonal T-cell proliferation and massive cytokine release, which contributes to systemic inflammation. Staphylococcal enterotoxins (e.g., SEA, SEB, SEC) function similarly as superantigens, activating up to 20% of T cells nonspecifically and inducing emesis via neural stimulation and mast cell degranulation in the gastrointestinal tract.^[92] The Panton-Valentine leukocidin (PVL), a heterodimeric cytotoxin encoded by lukS-PV and lukF-PV genes, forms transmembrane pores in leukocytes, leading to potassium efflux, cell lysis, and tissue necrosis, with particular prevalence in community-acquired strains.^[93]^[92] Other cytotoxins, such as alpha-hemolysin (Hla), form pores in host cell membranes, leading to lysis of erythrocytes, leukocytes, and epithelial cells.^[94] Enzymes facilitate invasion and persistence by modulating host barriers. Coagulase binds prothrombin to generate staphylothrombin, an active serine protease that cleaves fibrinogen into fibrin, encapsulating bacterial clumps to resist phagocytosis.^[95] Staphylokinase plasminogen activator converts plasminogen to plasmin, dissolving fibrin clots and promoting bacterial escape from protective barriers into surrounding tissues.^[92] Hyaluronidase depolymerizes hyaluronic acid in connective tissues, creating pathways for dissemination and enhancing abscess formation.^[92] Surface adhesins ensure firm attachment to host extracellular matrix and cells. Clumping factors A (ClfA) and B (ClfB), MSCRAMM proteins with N-terminal ligand-binding domains, interact with fibrinogen's γ-chain to mediate clumping, endothelial adhesion, and platelet aggregation.^[96] Serine-aspartate repeat (Sdr) family proteins, such as SdrC, SdrD, SdrE, and SdrG, feature tandem SD repeats for cell wall anchoring and bind diverse ligands including collagen (SdrD), bone sialoprotein (SdrC), and fibrinogen (SdrE), supporting colonization of bone, skin, and mucosal surfaces.^[92] Capsular polysaccharides, predominantly serotypes 5 (CP5) and 8 (CP8) in S. aureus clinical isolates, form a thin, loosely associated layer that sterically hinders opsonin access and reduces phagocytosis by neutrophils and macrophages, thereby promoting bloodstream survival and virulence in animal models.^[97] These capsules exhibit phenotypic switching through phase variation, involving reversible on-off expression that allows adaptation to immune pressures, as observed in experimental infections where non-encapsulated variants emerge.^[97]

Disease Mechanisms

Staphylococcus species initiate infection primarily through breaches in the skin or mucosal barriers, such as wounds, surgical sites, or indwelling medical devices like catheters, where the bacteria adhere to host tissues or foreign materials.^[92] Once attached, they form biofilms—structured communities embedded in a polysaccharide matrix—that shield the bacteria from host defenses and antibiotics, particularly on implants and prosthetic devices.^[98] From sites of asymptomatic colonization, such as the nasal mucosa or skin, staphylococci can disseminate hematogenously, seeding distant organs and leading to systemic infections like bacteremia or endocarditis.^[99] This spread is facilitated by the bacteria's ability to survive within the bloodstream by evading complement activation and phagocytosis.^[100] To establish infection, Staphylococcus employs sophisticated immune modulation strategies that subvert host defenses. A key mechanism involves staphylococcal protein A (SpA), a surface-anchored protein that binds the Fc region of immunoglobulin G (IgG), thereby inhibiting opsonization and subsequent phagocytosis by neutrophils and macrophages.^[101] This binding not only neutralizes existing antibodies but also cross-links B-cell receptors, inducing apoptosis in B cells and further impairing adaptive immunity.^[102] Additionally, superantigens like toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxins bind directly to major histocompatibility complex class II molecules and T-cell receptors outside the antigen-binding groove, triggering massive polyclonal T-cell activation and a cytokine storm characterized by excessive release of tumor necrosis factor-alpha (TNF-α), interleukin-2 (IL-2), and interferon-gamma (IFN-γ).^[103] This hyperinflammatory response contributes to tissue edema, hypotension, and organ dysfunction, amplifying the bacteria's pathogenic potential.^[104] Tissue damage in staphylococcal infections arises from localized and persistent inflammatory processes orchestrated by the pathogen. In abscess formation, coagulase enzyme converts fibrinogen to fibrin, creating a protective clot that traps and sequesters neutrophils, limiting their bactericidal activity while promoting necrotic debris accumulation and pus formation.^[105] This fibrin-neutrophil barrier isolates the infection but perpetuates chronic inflammation, as seen in skin and soft tissue abscesses.^[106] In osteomyelitis, biofilms formed by Staphylococcus aureus persist within bone matrix and osteocyte lacunar-canalicular networks, evading immune clearance and antibiotics due to their low metabolic state and physical inaccessibility, leading to bone necrosis and recurrent flares.^[107] These persistent communities can survive for years, contributing to treatment failure rates exceeding 40% in chronic cases.^[108] Coagulase-negative staphylococci (CoNS), such as Staphylococcus epidermidis, typically cause opportunistic infections associated with biomedical devices, where their production of a slime layer—a precursor to biofilm—enables adherence to synthetic surfaces like catheters and prosthetics, fostering chronic, low-grade inflammation without acute systemic effects.^[109] In contrast, Staphylococcus aureus drives primary, acute pathologies through potent exotoxins, including superantigens and cytotoxins like alpha-hemolysin, which directly lyse host cells and provoke rapid, severe tissue destruction and immune dysregulation.^[110] This distinction underscores CoNS's reliance on environmental niches for persistence versus S. aureus's aggressive exploitation of host vulnerabilities.^[4]

Clinical Aspects

Associated Diseases

Staphylococcus species, particularly Staphylococcus aureus, are responsible for a wide array of infections ranging from superficial skin conditions to life-threatening systemic diseases. These pathogens can invade various tissues, leading to localized inflammation or disseminated illness depending on the strain's virulence and the host's immune response. Coagulase-negative staphylococci (CoNS), such as S. epidermidis, primarily cause opportunistic infections in medical device settings. Symptoms often include pain, redness, swelling, and fever, with diagnostics relying on microbiological confirmation and imaging for deeper involvement.^[111] Skin and soft tissue infections are the most common manifestations of S. aureus, presenting as localized inflammatory processes. Impetigo appears as honey-crusted lesions on the face or extremities, typically in children, with symptoms of pruritus and mild discomfort.^[112] Cellulitis manifests as diffuse erythema, warmth, and edema in the dermis and subcutaneous layers, often accompanied by fever and lymphangitis if untreated.^[111] Abscesses form as painful, fluctuant collections of pus, commonly on the trunk or extremities, requiring incision for drainage.^[113] Folliculitis involves superficial pustules around hair follicles, causing itching or tenderness, particularly in areas like the beard or scalp.^[114] Systemic infections by S. aureus can lead to severe, disseminated disease. Bacteremia presents with high fever, chills, and hemodynamic instability, often seeding distant sites.^[100] Endocarditis features vegetations on heart valves, resulting in symptoms like murmur, embolic phenomena, and heart failure.^[111] Osteomyelitis involves bone inflammation, causing localized pain, swelling, and restricted movement, with chronic cases leading to sinus tracts.^[115] Toxic shock syndrome, mediated by TSST-1 superantigen, causes abrupt fever, rash, hypotension, and multi-organ failure.^[116] Staphylococcal scalded skin syndrome, induced by exfoliative toxins (ETA and ETB), results in widespread tender erythema, bullae, and desquamation, resembling a burn, primarily in infants.^[117] CoNS, especially S. epidermidis, are implicated in device-related infections. Prosthetic joint infections present with pain, effusion, and limited mobility at the implant site, often subacute in onset.^[4] Catheter-related bloodstream infections cause fever, rigors, and signs of sepsis, typically in hospitalized patients with indwelling lines.^[118] Foodborne illness from staphylococcal enterotoxins results in rapid-onset nausea, vomiting, abdominal cramps, and diarrhea, usually resolving within 24-48 hours without invasion.^[119] Diagnosis of staphylococcal infections emphasizes microbiological and imaging modalities. Culture from sterile sites, such as blood or tissue, confirms the pathogen and allows species identification, with S. aureus distinguished by coagulase positivity.^[1] For methicillin-resistant S. aureus (MRSA), PCR detection of the mecA gene provides rapid resistance profiling.^[120] Imaging, including MRI for osteomyelitis (showing bone marrow edema and abscesses) and echocardiography for endocarditis (revealing vegetations), aids in assessing deep-seated involvement.^[121]

Epidemiology and Risk Groups

Staphylococcus aureus, including its methicillin-resistant strains (MRSA), imposes a significant global health burden, with bacterial antimicrobial resistance (AMR) directly causing 1.14 million deaths in 2021 and contributing to 4.71 million more.^[122] The global resistance rate for MRSA was 27.1% (95% UI 23.5–31.0) in bloodstream infections, according to the 2025 Global Antimicrobial Resistance and Use Surveillance System (GLASS) report, with stable or decreasing trends in some regions.^[123] In hospital environments, MRSA accounts for a substantial proportion of S. aureus infections, with global MRSA nasal colonization rates around 2% in the general population.^[113] Community-acquired MRSA (CA-MRSA) cases have risen notably, with a 75% increase reported between 2016 and 2020 in some regions, particularly linked to outbreaks among athletes and prisoners where close contact facilitates spread.^[124] Transmission of Staphylococcus primarily occurs person-to-person through direct skin contact or indirectly via contaminated fomites such as shared personal items.^[113] In healthcare settings, outbreaks are common in neonatal intensive care units (NICUs), where coagulase-negative staphylococci (CoNS) represent the leading cause of late-onset sepsis due to device-related colonization and staff-mediated spread.^[125] Food handling contributes to outbreaks via cross-contamination during preparation, as S. aureus can produce heat-stable enterotoxins leading to staphylococcal foodborne illness.^[126] Certain populations face elevated risks for Staphylococcus infections due to underlying vulnerabilities or exposure patterns. Immunocompromised individuals, including those with HIV or diabetes, exhibit higher MRSA colonization and infection rates owing to impaired immune responses.^[127] Surgical patients and those with indwelling medical devices are particularly susceptible to invasive infections from healthcare-associated strains.^[128] Neonates in NICUs and elderly individuals with comorbidities represent high-risk groups for severe outcomes, while healthcare workers often show elevated nasal carriage rates from frequent patient interactions.^[129] Zoonotic transmission introduces additional epidemiological concerns, with livestock-associated MRSA (LA-MRSA), predominantly clonal complex 398, colonizing 24–86% of pig farmers and lower rates in cattle (31–37%) and poultry (9–37%) workers through direct animal contact.^[130] Surveillance trends since 2000 reveal increased LA-MRSA emergence linked to antibiotic overuse in agriculture, prompting enhanced monitoring in farming communities to curb spillover into human populations.^[131]

Prevention and Management

Control Strategies

Control strategies for Staphylococcus infections emphasize non-pharmacological measures to interrupt transmission and reduce colonization, particularly in healthcare and community settings. Adherence to hand hygiene protocols, including washing with soap and water or using alcohol-based sanitizers before and after patient contact, is a cornerstone of prevention in hospitals, as it significantly lowers the risk of Staphylococcus aureus spread.^[132] Contact precautions, such as wearing gloves and gowns during interactions with colonized or infected patients, further minimize direct and indirect transmission in acute care facilities.^[133] For known carriers, nasal decolonization using mupirocin 2% ointment applied twice daily to each nostril for five days has proven effective in eradicating nasal carriage of S. aureus, reducing postoperative infection risks in surgical patients.^[134] Environmental controls play a vital role in preventing Staphylococcus persistence on surfaces and in food. In healthcare settings, routine disinfection of high-touch surfaces with sodium hypochlorite (bleach) or quaternary ammonium compounds effectively eliminates S. aureus, including methicillin-resistant strains, when applied according to manufacturer guidelines.^[135]^[136] For food safety, rapid cooling of cooked foods to below 40°F (4°C) prevents S. aureus proliferation and toxin production, while pasteurization at temperatures above 145°F (63°C) for 30 minutes inactivates the bacterium in dairy and other products.^[137]^[138] Screening programs target high-risk individuals to enable early intervention. Preoperative nasal swabbing for methicillin-resistant S. aureus (MRSA) is recommended for patients undergoing major orthopedic or cardiac surgeries, allowing identification of carriers who can then be isolated under contact precautions to prevent nosocomial transmission.^[139]^[140] Efforts to develop vaccines have included trials of StaphVAX, a conjugate vaccine targeting capsular polysaccharide antigens, which showed initial promise in eliciting immune responses in hemodialysis patients but failed in phase III trials to significantly reduce S. aureus bacteremia compared to placebo.^[141]^[142] As of 2025, ongoing research includes promising candidates such as bivalent protein subunit vaccines offering protection in preclinical models of MRSA infections and epitope-based vaccines designed to elicit protective immunity by addressing immune imprinting challenges.^[143]^[144] Infection control bundles integrate multiple interventions to curb device-related Staphylococcus infections in intensive care units. For central line-associated bloodstream infections (CLABSI), bundles incorporating hand hygiene, maximal sterile barriers during insertion, and daily chlorhexidine washes have reduced overall rates by up to 50%, including those caused by coagulase-negative staphylococci.^[145] Similarly, ventilator-associated pneumonia bundles, which include elevating the head of the bed and oral care protocols, have achieved comparable reductions in Staphylococcus-linked cases by minimizing aspiration risks.^[146]

Antimicrobial Resistance and Treatment

Methicillin-resistant Staphylococcus aureus (MRSA) exhibits high-level resistance to β-lactam antibiotics primarily due to the acquisition of the mecA gene, which encodes penicillin-binding protein 2a (PBP2a). This protein has low affinity for most β-lactams, allowing continued cell wall synthesis even in the presence of these drugs.^[147]^[148] Vancomycin remains the first-line treatment for severe MRSA infections, but intermediate (VISA) and fully resistant (VRSA) strains are emerging, posing significant therapeutic challenges. VRSA resistance is conferred by the vanA gene cluster, typically acquired via plasmid transfer from enterococci, leading to high minimum inhibitory concentrations (MICs) of 512–1024 µg/mL.^[149]^[150] Coagulase-negative staphylococci (CoNS), particularly S. epidermidis, frequently display multidrug resistance, including to methicillin via mecA-mediated mechanisms and to aminoglycosides through enzymatic modification or efflux. Biofilm formation by S. epidermidis on indwelling devices further enhances tolerance to antibiotics, contributing to persistent infections.^[151]^[152]^[153] For severe staphylococcal infections, intravenous vancomycin or daptomycin is recommended as empiric therapy, while linezolid serves as an oral option for uncomplicated skin and soft tissue infections. Treatment duration for osteomyelitis typically ranges from 4 to 6 weeks, often requiring parenteral agents initially followed by highly bioavailable orals, guided by Infectious Diseases Society of America (IDSA) recommendations.^[154]^[155]^[156] Antimicrobial stewardship emphasizes combination therapies, such as adding rifampin to vancomycin for biofilm-associated infections like prosthetic joint infections, to improve outcomes and curb resistance emergence. Phage therapy trials as of 2025 show promise in targeting multidrug-resistant staphylococci, with the diSArm study demonstrating efficacy of intravenous bacteriophage therapy for S. aureus bacteremia in a phase II clinical trial, building on prior personalized phage-antibiotic combinations that demonstrated efficacy in compassionate-use cases for refractory infections.^[157]^[158] Resistance surveillance relies on Clinical and Laboratory Standards Institute (CLSI) breakpoints, which define susceptibility for key agents like vancomycin (MIC ≤2 µg/mL for S. aureus) to guide clinical decisions and track trends.^[159]^[160]

References

[1]
Staphylococcus - Medical Microbiology - NCBI Bookshelf - NIH
Bacteria in the genus Staphylococcus are pathogens of man and other mammals. Traditionally they were divided into two groups on the basis of their ability ...
[2]
Molecular Differentiation and Detection of AMR Genes from ... - NIH
Apr 23, 2025 · According to the List of Prokaryotic names with Standing in Nomenclature (LPSN), the Staphylococcus genus has approximately 89 species (accessed ...
[3]
The Genera Staphylococcus and Macrococcus - PMC
Members of the genus Staphylococcus form a coherent and well-defined group of related species that is widely divergent from those of the genus Micrococcus.
[4]
Coagulase-Negative Staphylococci - PMC - PubMed Central - NIH
As of 2014, the genus Staphylococcus consists of 47 species and 23 subspecies that are validly described (Fig. 3). Of these, 38 fulfill the categorization of a ...
[5]
Staphylococcal Infections: Host and Pathogenic Factors - PMC - NIH
May 18, 2021 · In 1880, the Scottish surgeon Sir Alexander Ogston first described staphylococci in pus from a surgical abscess in a knee joint: “The masses ...
[6]
Co-evolutionary aspects of human colonisation and infection by ...
In 1884, Rosenbach was able to isolate and grow these bacteria from abscesses and called them Staphyloccocus aureus because of the yellow-orange or “gold” ...
[7]
Etymologia: Staphylococcus - Emerging Infectious Diseases journal
In 1880, Scottish surgeon Sir Alexander Ogston first described staphylococci in pus from a surgical abscess in a knee joint: “the masses looked like bunches ...
[8]
Genus: Staphylococcus
- **Number of Validly Published Species and Subspecies**:
[9]
A Brief History of Staph - Proto Magazine
Jan 15, 2006 · 1881 STAPHYLOCOCCUS IS IDENTIFIED AS A CAUSE of wound infection by the Scottish surgeon Sir Alexander Ogston, who named it for the grape-like clusters.Missing: 1880 | Show results with:1880
[10]
Genetic Classification and Distinguishing of Staphylococcus ... - NIH
In this regard, the 16S rRNA sequence similarity has been shown to be very high, 90 to 99%, in 29 Staphylococcus species (20). S. caprae and S. capitis cannot ...
[11]
Staphylococcus nepalensis: A New Species from Nepal
The Genus Staphylococcus belong to the family Staphylococcaceae which comprise of 53 valid species. These are the normal ﬂora of mucocutaneous membranes of ...
[12]
Evolutionary and Functional Analysis of Coagulase Positivity among ...
Staphylococci are differentiated into coagulase-positive or coagulase-negative groups based on the capacity to promote clotting of plasma, a phenotype ...
[13]
Staphylococcus aureus in Animals | Microbiology Spectrum
The genus Staphylococcus currently comprises 81 species and subspecies (https://www.dsmz.de/bacterial-diversity/prokaryotic-nomenclature-up-to-date/prokaryotic ...Missing: valid | Show results with:valid
[14]
A Retrospective Descriptive Study of Staphylococcus Species ...
Apr 26, 2024 · There are forty-three known Staphylococcus spp. that can be divided into two broad categories, namely, coagulase-positive staphylococci (CoPS) ...Missing: valid | Show results with:valid
[15]
Coagulase-negative staphylococci (CoNS) as a significant ...
Jun 4, 2020 · This review article shows that coagulase-negative staphylococci (CoNS) are widely responsible for laryngological diseases.<|control11|><|separator|>
[16]
Population genomics of Staphylococcus pseudintermedius in ...
Jun 5, 2020 · We carried out a population genomics study of 130 clinical S. pseudintermedius isolates from dogs and cats in the New England region of the United States.Results · Methods · Phylogeny And Population...
[17]
Full article: Virulence factors in coagulase-positive staphylococci of ...
Coagulase-positive Staphylococci (CoPS) can exist as commensals in humans, companion and food-producing animals, but can cause severe or even lethal diseases.3. Virulence Factors... · 3.1. Staphylococcus... · 3.4. Other Coagulase...
[18]
Development of a novel core genome MLST scheme for tracing ...
Jul 22, 2022 · Genus-targeted markers for the taxonomic identification and monitoring of coagulase-positive and coagulase-negative Staphylococcus species. S ...
[19]
Staphylococcus epidermidis pan-genome sequence analysis ...
Jul 25, 2012 · The S. epidermidis genome, while relatively constant in size (<5% variance), was 80% core genes and 20% variable genes that were drawn from a ...<|control11|><|separator|>
[20]
Staphylococcus aureus Biological Agent Reference Sheet (BARS)
Nov 30, 2023 · Staphylococcus aureus are Gram-positive, catalase positive cocci belonging to the Staphylococcaceae family. They are approximately 0.5-1.5 μm in diameter.
[21]
The Cell Wall, Cell Membrane and Virulence Factors of ...
4. Staphylococcus aureus. Staphylococcus aureus is a Gram-positive cocci bacterium that can be found as a common commensal on human skin and in the human nasal ...4. Staphylococcus Aureus · 6. Bacterial Cell Components · 6.2. Cell MembraneMissing: morphology arrangement
[22]
The Staphylococcal Cell Wall - PMC - PubMed Central - NIH
The field of staphylococcal cell wall gradually gained its own significance as the complexity of its chemical structure and involvement in numerous cellular ...The Staphylococcal Cell Wall · Penicillin Binding Proteins · Murein Hydrolases In Cell...
[23]
Staphylococcus aureus golden pigment impairs neutrophil killing ...
A S. aureus mutant with disrupted carotenoid biosynthesis is more susceptible to oxidant killing, has impaired neutrophil survival, and is less pathogenic.
[24]
Mesosomes are a definite event in antibiotic-treated Staphylococcus ...
Mesosomes of Staphylococcus aureus ATCC 25923 treated with antibiotics were examined morphologically under the electron microscope.
[25]
The Response and Survival Mechanisms of Staphylococcus aureus ...
May 22, 2022 · Within a 10% NaCl concentration, the L-proline content was upregulated to increase osmotic stability. In addition, 20 hub genes were identified ...
[26]
Roles of Staphylococcus aureus Mnh1 and Mnh2 Antiporters in Salt ...
It successfully survives in high saline up to 25% NaCl, which is commonly found in canned foods. The low water activity (aw) makes the bacteria uniquely ...
[27]
Biochemical Test and Identification of Staphylococcus aureus
Aug 10, 2022 · Biochemical Test and Identification of Staphylococcus aureus ; Glucose, Positive (+ve) ; Lactose, Positive (+ve) ; Maltose, Positive (+ve).
[28]
Staphylococcus aureus - VetBact
Oct 23, 2025 · Taxonomy/phylogeny: Staphylococcus aureus, About 70 species and subspecies have been described within the genus Staphylococcus. S. aureus ...
[29]
Catalase Test - Virtual Interactive Bacteriology Laboratory
The enzyme, catalase, is produced by bacteria that respire using oxygen, and protects them from the toxic by-products of oxygen metabolism.Oxidase Test · Module · Coagulase TestMissing: respiration | Show results with:respiration
[30]
Role of respiratory NADH oxidation in the regulation of ...
Mar 23, 2020 · Staphylococcus aureus can use aerobic respiration, anaerobic/nitrate respiration fermentation, or a combination of these three metabolic ...
[31]
Staphylococcal Biofilm Development: Structure, Regulation, and ...
Aug 12, 2020 · This review provides an overview and an updated perspective on staphylococcal biofilms, describing the characteristic features of biofilm formation.
[32]
The Staphylococcus aureus Alternative Sigma Factor ςB Controls ...
ςB was mainly expressed during the stationary phase of growth and was repressed by 1 M sodium chloride. A sigB insertionally inactivated mutant was created. In ...
[33]
Main laboratory methods used for the isolation and identification of ...
The catalase test consists of a qualitative method for identifying this enzyme in the bacterial species analyzed, aiming at distinguishing between the genera ...
[34]
Identification of Staphylococcus aureus: DNase and Mannitol salt ...
Aug 13, 2010 · This study evaluated Mannitol salt agar and the deoxyribonuclease (DNase) test for improving the efficiency of the tube coagulase test in resource limited ...
[35]
Identification of Staphylococcus saprophyticus isolated from patients ...
The aim of this study was to compare three phenotypic methods for the identification of Staphylococcus spp. isolated from patients with urinary tract infection.
[36]
[PDF] Coagulase Test Protocol - American Society for Microbiology
Nov 11, 2010 · The slide test is performed first to detect bound coagulase, since it is a very quick procedure, and only a negative strain is further tested in ...
[37]
1.24: Coagulase Test - Biology LibreTexts
Feb 18, 2023 · This test determines the ability of the bacteria to produce bound coagulase. This exoenzyme will cause the conversion of fibrinogen in blood plasma to fibrin ...Coagulase · Laboratory Instructions · Slide Agglutination Test
[38]
Sensitivity and Specificity of an Improved Rapid Latex Agglutination ...
Although the slide coagulase test may be performed in <1 min, it lacks adequate sensitivity and specificity because some S. aureus strains lack clumping factor ...
[39]
[PDF] Bacteriological Analytical Manual Chapter 12: Staphylococcus aureus
Mar 1, 2016 · There has been considerable controversy about the significance and correct method of reading the coagulase test. Research results have indicated ...Missing: specificity | Show results with:specificity
[40]
Staphylococcus aureus Strains With a Negative Coagulase Tube ...
The coagulase tube test assay is used as a preliminary identification test; however, there are instances of S. aureus isolates testing negative. We hypothesized ...
[41]
Pastorex™ Staph Plus; Latex Agglutination Test #3556353 - Bio-Rad
The test provides rapid, simultaneous detection of the cell wall antigens, fibrinogen affinity antigen (clumping factor) and protein A, and capsular ...
[42]
Staphaurex™ Latex Agglutination Test 400 Tests/Kit
A qualitative latex slide agglutination test for the differentiation of Staphylococcus aureus from other Staphylococcus species isolates grown on agar.
[43]
Identification of Staphylococcus aureus: DNase and Mannitol salt ...
Aug 13, 2010 · The specificity and sensitivity of Mannitol salt agar/DNase/tube coagulase (sheep plasma) combination was 100% and 67%, respectively. Conclusion.
[44]
Thermostable DNase Is Superior to Tube Coagulase for Direct ... - NIH
The thermostable DNase test is more rapid, has greater sensitivity, and is nearly as simple and affordable as the DTC test and should be the test of choice for ...
[45]
VISLISI trial, a prospective clinical study allowing identification of a ...
Among other phenotypic similarities, S. lugdunensis shares with S. aureus a linked coagulase that yields a positive result in slide coagulase and rapid latex ...
[46]
Comparative performances of six agglutination kits assessed by ...
Six commercial agglutination tests designed for the identification of Staphylococcus aureus were compared by using a strain collection which included 512 ...
[47]
Studies of the Epidemiology of Staphylococcal Infection
Identification of Staphylococcus aureus: method for determination of coagulase production and mannitol fermentation in single medium. Bull. Johns Hopkins Hosp.
[48]
Average nucleotide identity-based Staphylococcus aureus strain ...
S. aureus genomes typically have a ~2.8-Mb chromosome and zero to a few plasmids. Like other bacterial pathogens, its success at responding to pathogenic niches ...
[49]
Whole-Genome Sequence of Staphylococcus aureus Strain LCT ...
The unclosed draft genome sequence analysis of S. aureus showed a genome size of 2,793,131 bp with a mean GC content of 32.70%, and the published genome size ...
[50]
Evolutionary genomics of Staphylococcus aureus: Insights into ... - NIH
Genetic variation in S. aureus is very extensive, with ≈22% of the genome comprised of dispensable genetic material. Eighteen large regions of difference were ...Missing: variability | Show results with:variability
[51]
Methicillin-resistant Staphylococcus aureus: an overview of basic ...
The core comprises ~75% of the 2.8 Mb genome of S. aureus and is highly conserved among strains. Much of the genetic diversity of MRSA and other pathogens ...
[52]
Comparative genome-scale modelling of Staphylococcus aureus ...
Jun 10, 2016 · The average S. aureus genome encodes 2,800 genes; therefore, the size of the core genome represents a high portion (56%, on average) of each S.
[53]
Mobile genetic elements of Staphylococcus aureus - PMC
Accessory genes typically have a different G + C content than those in the core genome, often because they are obtained from other species of bacteria [7, 8].
[54]
Structural Comparison of Three Types of Staphylococcal Cassette ...
SCCmec is a mobile genetic element characterized by the presence of terminal inverted and direct repeats, a set of site-specific recombinase genes (ccrA and ...
[55]
Classification of Staphylococcal Cassette Chromosome mec ...
SCCmec elements are classified by a hierarchical system into types and subtypes. Types are defined by the combination of (i) the type of ccr gene complex, which ...
[56]
A Review of Staphylococcal Cassette Chromosome mec (SCCmec ...
Oct 26, 2017 · (9) stated that SCCmec contains the following two essential components: the mec gene complex and the ccr gene complex. The mec gene complex ...
[57]
The Plasmidomic Landscape of Clinical Methicillin-Resistant ...
In pSK41, IS257 delimits segments that correspond to cointegrated copies of smaller plasmids, and this includes pUB110, which encodes the aadD aminoglycoside ...<|control11|><|separator|>
[58]
Molecular cloning of genetically active fragments of Bacillus DNA in ...
Plasmid pUB110 (approximately 2.8 x 10(6) daltons), originally detected in Staphylococcus aureus, specifies resistance to neomycin and has been transformed ...
[59]
Determination of aminoglycoside resistance in Staphylococcus ...
A method is described for identification of the genes conferring aminoglycoside resistance in Staphylococcus aureus by dot-blot and Southern blot techniques ...
[60]
Comparative analysis of prophages carried by human and animal ...
Prophages are a part of the accessory genome in a bacterial genome; however, identified prophages themselves have a pan-genome of 107,158 bp size. Notably, ...
[61]
ϕSa3mw Prophage as a Molecular Regulatory Switch of ...
ϕSa3int prophages encode several superantigens (SEA, SEl-K, and SEl-Q) ... Prophages of Staphylococcus aureus Newman and their contribution to virulence.
[62]
Quorum-sensing regulation in staphylococci—an overview - PMC
The role of two regulatory systems in staphylococci, the accessory gene regulator (Agr) system and the LuxS system, are discussed herein. Agr is considered the ...
[63]
Therapeutic Targeting of the Staphylococcus aureus Accessory ...
Jan 24, 2018 · This review summarizes our current understanding of the molecular mechanisms underlying agr quorum sensing and the regulation of agr expression.
[64]
Two-Component Systems of S. aureus: Signaling and Sensing ...
Dec 23, 2021 · Staphylococcus aureus encodes 16 two-component systems (TCSs) that enable the bacteria to sense and respond to changing environmental conditions.
[65]
The Staphylococcus aureus Global Regulator MgrA Modulates ...
The ArlRS two-component system regulates MgrA. To confirm that ArlRS regulates MgrA, we used a combination of transcriptional reporters and Western blots.
[66]
Staphylococci on ICE: Overlooked agents of horizontal gene transfer
Horizontal gene transfer plays a significant role in spreading antimicrobial resistance and virulence genes throughout the genus Staphylococcus, which includes ...
[67]
Genome hypermobility by lateral transduction - Science
Oct 12, 2018 · Here we report that the temperate bacteriophages of Staphylococcus aureus engage in a distinct form of transduction we term lateral transduction.Genome Hypermobility By... · Abstract · Delayed Prophage Excision...
[68]
Extensive Horizontal Gene Transfer during Staphylococcus aureus ...
Our data show that horizontal gene transfer occurs at very high frequency in vivo and significantly higher than that detectable in vitro.
[69]
Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus ...
We describe SigB as a crucial factor for bacterial adaptation and persistence, which represents a possible target for therapeutic interventions against chronic ...
[70]
Staphylococcus aureus RNAIII and Its Regulon Link Quorum ...
Sep 8, 2016 · Sigma factor SigB is crucial to mediate Staphylococcus aureus adaptation during chronic infections. PLOS Pathog. 11:e1004870 [Google Scholar] ...
[71]
Regulation of σB-Dependent Biofilm Formation in Staphylococcus ...
Sep 23, 2023 · This increased RNAIII expression decreases the expression of spa, a surface-associated adhesion factor.
[72]
Isolation of indigenous Staphylococcus sciuri from chromium ...
Aug 6, 2025 · A Cr(VI)-removing bacterium isolated from Cr-contaminated paddy field soil of Sundarbans was identified as Staphylococcus sciuri. Enrichment ...
[73]
Impact of fertilization by natural manure on the microbial quality of soil
The results showed a bacterial diversity very important indicating a fecal contamination like Bacteroides, Pseudomonas, Staphylococcus,… etc. Bacteria pertain ...Missing: decaying | Show results with:decaying
[74]
Staphylococci: symptoms, treatment, prevention - Institut Pasteur
They are part of the natural skin flora, specifically colonizing external mucous membranes, but they are also often found in the environment (in untreated water ...<|control11|><|separator|>
[75]
Characterization of Staphylococcus aureus isolates from raw milk ...
Jul 29, 2016 · Dairy animals with mastitis frequently shed S. aureus into the milk supply which can lead to food poisoning in humans. The aim of this study was ...
[76]
Raw Milk Misconceptions and the Danger of Raw Milk Consumption
Mar 5, 2024 · Bacteria present in raw milk are from infected udder tissues (e.g., mastitis causing bacteria), the dairy environment (e.g., soil, water, and ...Raw Milk Misconceptions And... · Raw Milk Is Not An Immune... · Raw Milk Is Not...
[77]
Review on Major Food-Borne Zoonotic Bacterial Pathogens - PMC
Jun 29, 2020 · Food animals are the major reservoirs of many food-borne zoonotic bacterial pathogens, and food products of animal origin are the main vehicles ...Missing: inanimate | Show results with:inanimate
[78]
Desiccation tolerance in Staphylococcus aureus - PubMed
This established a robust model of desiccation tolerance in which S. aureus has the ability to survive on dry plastic surfaces for more than 1,097 days. Using a ...
[79]
How long do nosocomial pathogens persist on inanimate surfaces ...
The most common nosocomial pathogens may well survive or persist on surfaces for months and can thereby be a continuous source of transmission.
[80]
(PDF) Staphylococcus delphini sp. nov., a Coagulase-Positive ...
Aug 5, 2025 · The species Staphylococcus delphini is a Gram-positive bacterium belonging to the Staphylococcus intermedius group, being a mucosa colonizer and ...
[81]
Staphylococcus delphini - VetBact
Mar 8, 2023 · Reservoir: Mustelidae (e.g. minks, weasels etc.) Disease: S. delphini has been isolated from aquarium-raised dolphins with skin lesions.
[82]
Staphylococcus aureus Epidemiology in Wildlife: A Systematic Review
Staphylococcus aureus is a common bacterial colonizer of humans and a variety of animal species. Many strains have zoonotic potential, moving between humans ...Missing: inanimate | Show results with:inanimate
[83]
Staphylococcus aureus Nasal Colonization - PubMed Central - NIH
To successfully colonize human nares, S. aureus needs to establish solid interactions with human nasal epithelial cells and overcome host defense mechanisms.<|control11|><|separator|>
[84]
Colonization of patients, healthcare workers, and the environment ...
Referral case 4 was colonized with HA-MRSE ST215 in the perineum, the axilla and the insertion site of the central venous catheter; also ST2 were obtained from ...
[85]
Staphylococcal Carriage Status: Implications, Mechanisms ... - NIH
Jun 28, 2023 · In addition, Staphylococcus isolated from colonization sites possess higher levels of regulatory factors - such as SarA, Rot, and MgrA ...
[86]
Host- and microbe determinants that may influence the success of S ...
Several host and microbe determinants are assumed to be associated with colonization. These include the presence and expression level of bacterial adhesins, ...
[87]
Global epidemiology of asymptomatic colonisation of methicillin ...
Jan 31, 2024 · aureus colonisation was 25.1% (95% CI 21.4 to 28.8) and MRSA colonisation was 3.4% (95% CI 2.8 to 4.1). The clones of MRSA strains included ...
[88]
Human Colonization and Infection by Staphylococcus ...
Feb 25, 2023 · pseudintermedius has been implicated in various cases of human colonization and infections, mostly due to close contact between companion dogs ...
[89]
Transmission of Staphylococcus aureus from mothers to newborns
Newborns of carrier mothers are at risk to acquire S. aureus colonization. Most newborns of carrier mothers are colonized within the first month of life.
[90]
Maternal-Fetal Perinatal Transmission of Staphylococcal Infections
Jun 16, 2020 · We report the story of two newborns who had pustular-bullous skin lesions at birth and responded successfully to antistaphylococcal antibiotics.
[91]
Pathogenicity and virulence of Staphylococcus aureus - PMC
The main mechanism underlying this infection route is the capacity of S.aureus to adhere to the devices' plastic material as well as to the matrix molecules ...
[92]
Staphylococcus aureus Capsular Polysaccharides - PMC
The capsular polysaccharides expressed by S. aureus are clearly important in the pathogenesis of staphylococcal infections.
[93]
Staphylococcus aureus Evasion of Host Immunity in the Setting of ...
S. aureus biofilm increases antibiotic resistance, impairs host immunity, and uses secreted proteins and the agr system for immune evasion.Cell Wall-Anchored Proteins · Beyond Biofilm: Canalicular... · Beyond Biofilm: Soft Tissue...
[94]
Staphylococcal Infections - Infectious Diseases - Merck Manuals
Staphylococcal pneumonia may be a primary infection or result from hematogenous spread of S. aureus infection elsewhere in the body (eg, IV catheter infection, ...
[95]
Staphylococcus aureus Infections: Epidemiology, Pathophysiology ...
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis.Missing: genus | Show results with:genus
[96]
Effect of protein A on staphylococcal opsonization - PubMed
Extracellular (purified) protein A decrease the opsonic activity of all sera tested including IgG-deficient serum. It is proposed that when IgG is not present ...
[97]
Staphylococcal protein A inhibits complement activation by ... - PNAS
Feb 9, 2021 · Here we demonstrate that staphylococcal protein A (SpA) from Staphylococcus aureus specifically blocks formation of IgG hexamers and downstream activation of ...<|separator|>
[98]
Bacterial superantigen toxins induce a lethal cytokine storm by ... - NIH
Superantigens from Staphylococcus aureus and Streptococcus pyogenes induce toxic shock and sepsis by activating an immune response, orders of magnitude ...
[99]
Superantigens promote Staphylococcus aureus bloodstream ...
SAgs are the etiological agent of toxic shock syndrome, in which T cell activation caused by SAgs released from S. aureus triggers a systemic “cytokine storm” ...
[100]
Pathogenesis of Staphylococcus aureus Abscesses - PMC
Such molecules include those that recruit neutrophils, cause host cell lysis, and are involved in the formation of the fibrin capsule surrounding the abscess.
[101]
Two Distinct Coagulase-Dependent Barriers Protect Staphylococcus ...
Neutrophils are considered to be the first line of cellular defense of localized infections. Moreover, their predominance in abscesses formed by staphylococci ...
[102]
Evolving concepts in bone infection: redefining “biofilm”, “acute vs ...
Jul 15, 2019 · Staphylococcus aureus is responsible for the majority of chronic osteomyelitis cases and is often considered to be incurable due to bacterial ...
[103]
Can intracellular Staphylococcus aureus in osteomyelitis be treated ...
Aug 12, 2022 · Approximately 40% of treatments of chronic and recurrent osteomyelitis fail in part due to bacterial persistence. Staphylococcus aureus ...
[104]
Virulence Factors in Coagulase-Negative Staphylococci - MDPI
Coagulase-negative staphylococci (CoNS) have emerged as major pathogens in healthcare-associated facilities, being S. epidermidis, S. haemolyticus and, more ...
[105]
Staphylococcus aureus: A Review of the Pathogenesis and ...
Nasal, skin, and oropharyngeal colonization are reservoirs for invasive infections, with biofilm persistence and horizontal gene transfer exacerbating ...
[106]
Staphylococcus aureus Infection - StatPearls - NCBI Bookshelf - NIH
Staphylococcus aureus is a gram-positive bacteria that cause a wide variety of clinical diseases. Infections caused by this pathogen are common both in ...
[107]
Skin Infections Caused by Staphylococcus aureus - PMC - NIH
Staphylococcus aureus is the most common pathogen involved in skin infections worldwide, regardless of the patient's age, the climate or geographical area.
[108]
Clinical Overview of Methicillin-resistant Staphylococcus aureus ...
Jun 27, 2025 · Most S. aureus skin infections, including MRSA, appear as a bump or infected area on the skin that might be: Red. Swollen. Painful ...
[109]
Folliculitis - StatPearls - NCBI Bookshelf - NIH
Aug 8, 2023 · The diagnosis of folliculitis is clinical. In general, no diagnostic testing or radiographic evaluation is necessary to diagnose this condition ...
[110]
Staphylococcus aureus Toxins: An Update on Their Pathogenic ...
Abscesses, lung infections, bacteremia, endocarditis, and osteomyelitis are all caused by S. aureus infections in humans [3]. With the appearance of ...
[111]
Staphylococcal and Streptococcal Superantigen Exotoxins - PMC
This review begins with a discussion of the large family of Staphylococcus aureus and beta-hemolytic streptococcal pyrogenic toxin T lymphocyte superantigens.
[112]
Staphylococcal Scalded Skin Syndrome - StatPearls - NCBI Bookshelf
Jun 22, 2025 · Young children possess a relatively low concentration of Dsg1 and exhibit diminished renal clearance of exfoliative toxins, which heightens ...Continuing Education Activity · Introduction · Etiology · Pathophysiology
[113]
Are coagulase-negative staphylococci virulent? - PubMed
Nov 29, 2018 · Content: Most catheter-related and prosthetic joint infections as well as most other device-related infections are caused by CoNS ...
[114]
About Staph Food Poisoning - CDC
Apr 16, 2024 · Testing and diagnosis ... Laboratory tests can detect toxin-producing Staph in stool, vomit, and foods. However, these tests are usually not ...
[115]
PCR ID: MRSA Strains & Antibiotic Resistance Profiles
This study is suggestive that the PCR for detection of mecA gene is a fast, accurate and valuable diagnostic tool, particularly in hospitals.
[116]
Osteomyelitis - StatPearls - NCBI Bookshelf - NIH
May 31, 2023 · Of all the imaging modalities currently in use, MRI has the highest combined sensitivity and specificity (78% to 90% and 60 % to 90% ...
[117]
Antimicrobial resistance
### Summary on Staphylococcus aureus/MRSA Prevalence and Global Burden
[118]
Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022
### Summary of MRSA Prevalence from 2022 GLASS Report
[119]
Global prevalence and dynamics of mecA and mecC genes in MRSA
Human mecA-positive MRSA had 21.77 % prevalence (95 % CI: 9.08–43.67 %), animal samples had 7.08 % prevalence (95 % CI: 3.93–12.42 %), and worldwide prevalence ...
[120]
Fact Sheet: MRSA in Correctional Facilities and Shelters
Apr 30, 2024 · Between 2016 and 2020, there was a 75% rise in CA-MRSA cases ... MRSA cases (including community- and hospital-acquired cases).<|separator|>
[121]
Coagulase-negative staphylococcal infections in the neonatal ...
Coagulase-negative staphylococci (CoNS) are the most commonly isolated pathogens in the neonatal intensive care unit (NICU).
[122]
Staphylococcus aureus and Staphylococcal Food-Borne Disease
aureus is a common causative agent of bovine mastitis in dairy herds. A study conducted in Minnesota to estimate the heard prevalence of S. aureus from bulk ...
[123]
Risk factors for methicillin-resistant Staphylococcus aureus ...
Jan 18, 2022 · MRSA colonization and infection in HIV-infected patients is associated with a number of risk factors.Missing: immunocompromised neonates elderly workers
[124]
Staphylococcus aureus Basics - CDC
Apr 15, 2024 · Staphylococcus aureus (staph) is a bacterium commonly found on the skin and in the nose of about 30% of individuals.Missing: genus | Show results with:genus
[125]
Preventing Health Care–Associated Infections - NCBI - NIH
The higher likelihood of infection is reflected in vulnerable patients who are immunocompromised because of age (neonate, elderly), underlying diseases, ...
[126]
Livestock-Associated Methicillin-Resistant Staphylococcus aureus ...
Sep 12, 2019 · LA-MRSA CC398 colonization has been detected in 24–86% of pig-, 31–37% of cattle-, and 9–37% of poultry-farmers, as well as 44–45% of pig-care ...
[127]
Methicillin-resistant Staphylococcus aureus: livestock-associated ...
This alarming overuse of antibiotics has given rise to considerable antibiotic resistance by most bacteria, causing what used to be common infections to become ...Missing: post- | Show results with:post-
[128]
Clinical Safety: Hand Hygiene for Healthcare Workers - CDC
Feb 27, 2024 · Handwashing with water and soap (e.g., plain soap or with an antiseptic). · Antiseptic hand rub (alcohol-based foam or gel hand sanitizer).
[129]
Strategies to Prevent Hospital-onset Staphylococcus aureus ... - CDC
Apr 15, 2024 · Core strategies · Adherence to hand hygiene, Standard Precautions, and Contact Precautions · Adequacy of room cleaning and environmental services ...
[130]
Intranasal Mupirocin to Prevent Postoperative Staphylococcus ...
Treatment with mupirocin ointment can reduce the rate of nasal carriage and may prevent postoperative S. aureus infections.<|separator|>
[131]
Chemical Disinfectants | Infection Control - CDC
Nov 28, 2023 · The quaternaries sold as hospital disinfectants are generally fungicidal, bactericidal, and virucidal against lipophilic (enveloped) viruses.
[132]
Hydrogen peroxide and sodium hypochlorite disinfectants are more ...
Dec 17, 2018 · Common antimicrobials used for disinfecting surfaces in healthcare facilities include quaternary ammonium compounds, hydrogen peroxide, and ...<|separator|>
[133]
Preventing Staphylococcal (Staph) Food Poisoning - CDC
Apr 22, 2024 · Prevention tips Staph and other germs can multiply rapidly in food left at room temperature – or in the "danger zone" between 40°F and 140°F. ...Missing: pasteurization cooling FDA
[134]
https://www.nejm.org/doi/full/10.1056/NEJMoa003069
[135]
MRSA and MSSA Preoperative Screening & Decolonization
Screen for Staphylococcus aureus (MRSA and MSSA) preoperatively for procedures, especially arthroplasty procedures. Intranasal mupirocin is a topical ...
[136]
[PDF] Guide to preoperative testing: Adult MRSA screening and ... - GIRFT
1. Indications for MRSA screening. 2. Mode of swab. 3. Duration of validity. It also summarises current guidance on suppression therapy for completeness ...
[137]
Use of a Staphylococcus aureus Conjugate Vaccine in Patients ...
In patients receiving hemodialysis, a conjugate vaccine can confer partial immunity against S. aureus bacteremia for approximately 40 weeks.
[138]
The Candidate Antigens to Achieving an Effective Vaccine against ...
Results of the second phase III studies showed no reduction in S. aureus infections in the StaphVAX group when compared to the placebo group. StaphVAX was shown ...
[139]
[PDF] Bloodstream Infection Event (Central Line-Associated ... - CDC
1 CLABSIs are serious infections typically causing a prolongation of hospital stay, increased cost, and risk of mortality. CLABSIs can be prevented through ...
[140]
Central Line–Associated Bloodstream Infection Reduction and ...
Apr 7, 2016 · Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. J Qual Patient Saf 2005;31.Google ...
[141]
Molecular Determinants of β-Lactam Resistance in Methicillin ...
The acquired mecA gene encodes penicillin-binding protein 2a (PBP2a), which takes over the activities of endogenous PBPs and, due to its low affinity for β- ...
[142]
Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus ...
High-level resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) is due to expression of penicillin-binding protein 2a (PBP2a) ...
[143]
Laboratory Testing for Vancomycin-resistant Staphylococcus aureus
Apr 15, 2024 · The VanA gene typically confers (provides) high-level vancomycin resistance (MICs= 512-1024 µg/ml). All VRSA isolates detected and confirmed in ...
[144]
Vancomycin Resistance in Staphylococcus aureus - PubMed - NIH
Jun 23, 2017 · Resistance in VRSA is conferred by the vanA gene and operon, which is present on a plasmid. Although treatment of VRSA infections is ...
[145]
Difficult-to-Treat Pathogens: A Review on the Management of ...
May 4, 2023 · The CoNS, especially S. epidermidis, are the most common cause of nosocomial bloodstream infection—responsible for 30% to 40% of these ...
[146]
Antibiotic Resistance and Biofilm Production in Staphylococcus ...
Biofilm is believed to make clinical SE strains more resistant to administered antibiotics and to host defense mechanisms and highly contributed to cause NI in ...
[147]
Antimicrobial Resistance Profiles of Coagulase-Negative ... - NIH
Jun 17, 2021 · In addition, some species (e.g., Staphylococcus epidermidis) are capable of forming biofilms on indwelling medical devices, making CoNS ...<|separator|>
[148]
Clinical Practice Guidelines by the Infectious Diseases Society of ...
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of ...Executive Summary · Sstis · Antimicrobial TherapyMissing: immunocompromised | Show results with:immunocompromised
[149]
Systemic Antimicrobial Therapy in Osteomyelitis - PMC
Vancomycin has been the treatment of choice for methicillin-resistant Staphylococcus aureus osteomyelitis, but there are several newer parenteral and oral ...
[150]
Skin and Soft Tissue Infections - IDSA
Jul 15, 2014 · The focus of this guideline is the diagnosis and appropriate treatment of diverse SSTIs ranging from minor superficial infections to life-threatening ...
[151]
Staphylococcus aureus | Johns Hopkins ABX Guide
Aug 9, 2025 · Vancomycin 15 mg/kg IV q12h for ≥ 6 weeks PLUS gentamicin 1 mg/kg IV q8h (or 1.5 mg IV q12 h) for 1st 2 weeks PLUS rifampin 300 mg PO q8h for ≥ ...
[152]
Bacteriophage therapy for drug-resistant Staphylococcus aureus ...
Jan 31, 2024 · This article provides a comprehensive overview of phage biology, animal models, diverse clinical case treatments, and clinical trials in the context of drug- ...Missing: stewardship | Show results with:stewardship
[153]
Changes in Methodology and Breakpoints for Staphylococcus spp ...
May 1, 2025 · Tedizolid disk diffusion breakpoints for staphylococci, beta-hemolytic streptococci and viridans streptococci were added to CLSI M100 in 2024.Missing: surveillance | Show results with:surveillance
[154]
Laboratory Testing for Methicillin (oxacillin)-resistant ... - CDC
Jun 27, 2025 · The oxacillin and cefoxitin breakpoints for Staphylococcus aureus (S. aureus) are different than those for other staphylococci. Overview.Missing: surveillance | Show results with:surveillance